Slaughter Lab
The Slaughter Lab aims to improve outcomes important to neonatal patients and their families through large patient-focused cohort investigations and randomized trials. The patient-centered research program focuses on neonatal pharmacoepidemiology and comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient characteristics.
- Large, Ongoing NIH-funded Investigations Include: Environmental Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio
- Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
- The PIVOTAL Trial: A Randomized Trial of Catheter Closure Versus Responsive Management of Patent Ductus Arteriosus (PDA) in Preterm Infants
Lab Staff
Jonathan Slaughter, MD, MPH
Principal Investigator
Jonathan.Slaughter@NationwideChildrens.org
Jonathan Slaughter, MD, MPH, is a neonatologist and principal investigator in the Center for Perinatal Research at the Abigail Wexner Research Institute at Nationwide Children's Hospital. He is also a professor of Pediatrics at The Ohio State University.
